Kure Therapeutics Inc Share Price

NASDAQ: OKUR

Small Cap

$2.46

+0.07

(+2.93%)

Live

as on September 18, 2025 at 10:20 pm IST

$₹

Kure Therapeutics Inc Stock Performance

as on September 18, 2025 at 10:20 pm IST

Day's Low
Day's High
$2.4
Day's Price Range
$2.47
$2.46
2.44%
Downside
0.41%
Upside
52 Week's Low
52 Week's High
$1.7
52-Week Price Range
$20
$2.46
30.89%
Downside
712.98%
Upside

Kure Therapeutics Inc share price movements today

Previous Close: $2.39
Open: $2.44
Volume: 195.7K
Day's Low - High: $2.4 - $2.47
52 Week Low - High: $1.7 - $20

Kure Therapeutics Inc Historical Returns

1 Month Return: -14.64 %
3 Month Return: -1.24 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Kure Therapeutics Inc Stock Fundamentals & Key Indicators

Check Kure Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.1M

EPS (TTM)

-4.572

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

10598500.00%

Kure Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kure Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Kure Therapeutics Inc	NA	$32.1M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Kure Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Kure Therapeutics Inc Stock has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-85% versus previous 30 day period

Kure Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	0	0	0	0	0	0	0	0
Operating Income	-8	-8	-20	21	-9	-14	-4	-33	-17	-16
EBITDA	-8	-8	-39	21	-9	-13	3	-31	-16	-15
Interest Expense	-	-	-	-	-	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-8	-19	18	-9	-14	-3	-35	-15	-15
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-8	-8	-19	18	-9	-14	-3	-35	-15	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Kure Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-
Gross Profit	0	0	0
Operating Income	-29	-36	-54
EBITDA	-29	-34	-51
Interest Expense	-	-	0
Depreciation	0	0	0
Income Before Tax	-29	-35	-52
Income Tax Expense	-	-	-
Net Income	-29	-35	-52
Net Profit Margin	0.00%	0.00%	0.00%

Kure Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-36	18	-9	-14	6	-35	-15	-15
Operating Cash Flow	-11	-18	9	-10	-6	-2	-21	-14	-13
Investing Cash Flow	0	21	29	0	0	25	-45	0	0
Financing Cash Flow	0	0	-11	0	5	2	114	0	-
Change in Cash	-11	2	18	-10	0	24	50	-14	-13

Kure Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-39	-29	-35	-52
Operating Cash Flow	-37	-26	-34	-51
Investing Cash Flow	-23	-1	0	15
Financing Cash Flow	132	26	53	116
Change in Cash	71	-1	18	80

Insights on Kure Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 152.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 205.8%
NEGATIVE IMPACT
Price Dip
In the last 1 month, OKUR stock has moved down by -14.6%

About Kure Therapeutics Inc

OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, the Company is building a pipeline of tumor-agnostic candidates. It is developing OKI-219, a selective PI3KaH1047R inhibitor, as its lead program. It is engaged in targeting oncogenic PI3Ka and has multiple programs designed to enable targeting of this key oncogene. It is focused on delivering highly selective drug candidates that preserve wild-type PI3Ka while targeting the PI3Ka-mutated cancers, initially in advanced breast cancer. Its lead product candidate, OKI-219, is advancing in a phase I clinical trial. It also focuses on a development candidate targeting the most common PI3Ka mutations, such as H1047R, E545K, and E542K. Additionally, it is developing an allosteric inhibitor molecule.

Organisation	Kure Therapeutics Inc
Headquarters	6707 Winchester Circle, Boulder, CO, United States, 80301
CEO	Dr. Nicholas A. Saccomano Ph.D.
E-voting on shares	Click here to vote

Key Management of Kure Therapeutics Inc

Name	Title
Dr. Samuel Agresta M.D., M.P.H.	Chief Medical Officer
Dr. Dylan Hartley Ph.D.	Chief Scientific Officer
Dr. Kevin S. Litwiler Ph.D.	Senior Vice President of DMPK & Clinical Pharmacology
Ms. Roberta Alton	Senior VP of Clinical Operations
Dr. Nicholas A. Saccomano Ph.D.	President, CEO & Director
Mr. Rogan P. Nunn J.D.	General Counsel & Secretary
Dr. James Blake Ph.D.	Senior Vice President of Computational Drug Discovery
Dr. Mark L. Boys Ph.D.	Senior Vice President of Discovery Chemistry
Mr. Jason A. Leverone CPA	Chief Financial Officer

FAQs

What is Kure Therapeutics Inc share price today?

Kure Therapeutics Inc share price today is $2.46 as on September 18, 2025 at 10:20 pm IST. Kure Therapeutics Inc share today touched a day high of $2.47 and a low of $2.4.

What is the 52 week high and 52 week low for Kure Therapeutics Inc share?

Kure Therapeutics Inc share touched a 52 week high of $20 on October 7, 2024 and a 52 week low of $1.7 on May 13, 2025. Kure Therapeutics Inc stock price today i.e. September 18, 2025 at 10:20 pm IST is trending at $2.46,which is 87.70% down from its 52 week high and 44.71% up from its 52 week low.

What is Kure Therapeutics Inc's market capitalisation today?

Kure Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 10:20 pm IST.

How to invest in Kure Therapeutics Inc Stock (OKUR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kure Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kure Therapeutics Inc Shares that will get you 0.6098 shares as per Kure Therapeutics Inc share price of $2.46 per share as on September 18, 2025 at 10:20 pm IST.

What is the minimum amount required to buy Kure Therapeutics Inc Stock (OKUR) from India?

Indian investors can start investing in Kure Therapeutics Inc (OKUR) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 10:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Kure Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 10:37 pm IST). Based on Kure Therapeutics Inc share’s latest price of $2.46 as on September 18, 2025 at 10:20 pm IST, you will get 4.0650 shares of Kure Therapeutics Inc. Learn more about fractional shares .